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Palm oil esters are high molecular weight esters oil that has been newly 
synthesized by University Putra Malaysia researchers. It has received a lot of 
attention for its pharmaceutical and chemical application. Piroxicam is a 
nonsteroidal anti-inflammatory drug with analgesic and antipyretic activity. It 
has low solubility in water as well as in oil with Log P value of 1.8. 
Generally, drugs with Log P value of more than 0.5 are needed to be 
formulated into a modified dosage form. One of these formulations is nano 
sized cream. Hence, the ability of formulating of these tricky drugs into 
dispersed system is questionable. The aim of this study is to investigate the 
ability of palm oil esters to be the oil phase for formulation of piroxicam into 
O/W nano-cream. Three points were selected from prepared pseudoternary 
diagram of palm oil esters and different Tween and Span mixtures. Piroxicam 
solubility and partition coefficient in oil and external phase was detected. 
Rheological properties, droplet size, structural properties and zeta potential of 
the dispersion system containing piroxicam were measured. O/W cream was 
formed with droplet size measurement by TEM of less than 100 nm. It could 
be concluded that palm oil esters is suitable oil for the formulation of suitable 
nano-cream containing piroxicam.    
 
Keywords: Palm oil esters; Piroxicam Solubility; partition coefficient; 
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Introduction  
Palm oil esters (POEs) are a constituent of modified 
form of Palm olein oil known simply as palm oil. It is 
a main and important agriculture commodity of which 
received great attention from researchers especially 
Malaysian researchers. Structurally, palm oil is a 
mixture of triglyceride compound. Palm oil is edible 
oil and is used throughout the world as main 
ingredient in many food products. Palm oil, as a raw 
material, had also attracted many researchers to study 
its use in topical delivery products  and in the effort to  
 
synthesise new derivatives with beneficial properties 
for chemical and pharmaceutical applications. 
Universiti Putra Malaysia (UPM) had led the way in 
the production of new derivatives of palm oil [1]. 
Palm oil had been discovered to react with oleyl 
alcohol and the reaction was catalysed by the use of 
lipase enzyme to produce POEs contained high 
molecular weight esters of alcohol with an even 
number of carbon ranging from 12-32 [2]. It was 
found that POEs has skin hydration activity of 40.7% 
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after 90 minutes of its application [3]. The emollient 
effect of POEs had been proven thereby making this 
oil highly recommendable for its incorporation into 
the topical preparation as oil phase.  
Tween and Span are nonionic surfactants which are 
widely used in topical preparation. These surfactants 
are compatible with acidic and basic media and less 
liable to hydrolysis and degradation by micro-
organism [4]. These surfactants are non-toxic 
surfactants and can be used safely for the topical 
delivery. It is reported that the recommended dose of 
Tween and Span are 25 mg/kg for human body per 
day [5]. Water insoluble drugs need to be formulated 
into suitable modified dosage form to improve their 
bioavailability. Emulsion is one of the desired and 
suitable dosage forms for water insoluble drugs. If the 
drug has enough lipophilic properties, it will be easy 
to formulate it in an emulsion by direct incorporation 
in the oil phase [6].  However, many drugs possess 
low solubility in oil as well as in water.  
Piroxicam is one of those drugs that have low 
solubility in water as well as in oil. Piroxicam has 
been formulated in different semi solid dosage forms 
to achieve drug targeting to joints and muscles at the 
site of application [7,8]. The main obstacle with 
topical formulation of Piroxicam is its low water-oil 
solubility that makes the loading of the desired 
amount of the drug in the formula so complicated. 
Many studies have been done to formulate Piroxicam 
topical delivery in a well solublized and bioavailable 
O/W cream by using different oil types. Piroxicam 
was found to have a solubility of less than 1mg/gm in 
cotton seed oil, laprafac, olive oil, sesame oil and 
soybean oil. On the other hand, oleic acid and 
triacetin are the only oils in which Piroxicam 
solubility is more than 4 mg/g [9].  
1. Effect of the synthesized POEs in the formation of 
nano-cream containing piroxicam and its 
characterization as a topical dosage form has not yet 
been studied before. Therefore, this study was aimed 
to discover the suitability of POEs to form nano-
cream for use as a dosage form to deliver piroxicam 
topically. The present study was performed in various 
stages encompassing the following objectives: 
measurement of piroxicam solubility in the oil and the 
effects of different surfactant mixture on this drug´s 
solubility to ensure that enough drug can be 
incorporated to produce nano-cream containing the 
required strength of drug. Then, to study the effects of 
surfactant HLB, surfactant concentration, drug 
concentration and pH of external phase on rheological 
properties of the prepared nano-creams which should 
possess visco-elastic properties. As a main objective 
of this study, to ensure obtaining a nano sized 
droplets of the points selected from transparent area 
of phase diagrams, measurement of droplet sizes of 
the formulated creams were aimed to be determined. 
Additionally, to determine zeta potential of formul-
ated nano-creams to make certain that they are within 
the limit of ±30, this can ensure that the droplets do 
not coalesce. Lastly, to determine partition coefficient 
of piroxicam into POEs and the three phosphate 
buffer of different pH as those used as the external 
phase to study the effects of pH on the distribution of 
the drug between the internal and external phases. 
 
Materials and methods 
Materials 
Potassium dihydrogen phosphate and sodium 
hydroxide were supplied by R & M chemicals (UK). 
Orthophosphoric acid and hydrochloric acid were 
supplied by BDH (UK). Acetonitrile was purchased 
from J.T. Baker (USA). Palm oil ester was a gift from 
UPM. Tween 80, Tween 85, Span 20, Span 85 and 
sodium benzoate were purchased from Sigma-Aldrich 
(USA). Piroxicam was supplied by Novaltek 
Lifescience, Shanghai (China).  
 
Methods 
Piroxicam solubility measurement 
Mixtures of surfactants (emulsifier) were added and 
dissolved into the POEs (oil phase) at selected oil: 
surfactant ratios. Excess piroxicam was added into 
each mixture of surfactant and oil phase. The 
mixtures were vortexed continuously using a 
magnetic stirrer at 750 rpm, 25±0.5ºC for 48 hours. 
The mixtures were centrifuged at 3600 rpm for 45 
min and the supernatant was separated and analysed 
by UV at 334 nm for piroxicam content. The drug 
was extracted from the oil surfactant mixture with a 
solvent containing 2.04 ml of 12 M HCl in 500 ml of 
acetonitrile [10]. The solubility of piroxicam was also 
estimated in palm oil ester, water, phosphate buffer 
pH 4, pH 6, pH 7.4, Span 20 and Tween 80. 
Rheological measurements 
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The rheological measurements were carried out by 
using a rheometer (rheologica instrument AB, 
Sweden). The system was equipped with a cone and 
plate measuring head (plate diameter 40 mm). About 
0.5 g of the sample to be analysed was placed on the 
plate and left to equilibrate with the controlled 
temperature (25±0.1°C) for 3 minutes before bringing 
down the cone. This is not only to ensure the thermal 
equilibration of the sample but the structural 
equilibrium also. Excess sample was swiped away 
with a tissue paper. The shear stress is applied in 
increasing manner at a rate of 10 pascal/2 second and 
the shear rate measurements were recorded as 
reported by Welin-Berger et al. [11]. The experiment 
was repeated for other samples. Rheograms were 
drawn by plotting shear stress on x axis and shear rate 
on the y axis.  
As the systems exhibited a non Newtonian flow 
whereas the flow did not start from zero, their 
rheological behaviors were measured according to the 
following equation for plastic liquid (those having 
yield value):   
Log G = N Log (S –F) - Log n 
Where G is the shear rate in sec-1, S is the shear 
stress in Pascal, F is the yield value, n is the viscosity 
and N is the slope of log (S-F) against log G plot. 
When N is 1, plastic flow with Bingham´s model is 
indicated. The effects of HLB value of surfactant, 
surfactant concentration, piroxicam concentration and 
pH of external phase on the rheological behavior were 
studied by comparing different values and 
concentrations. 
 
Method of preparation of selected formulation 
Formulae E14 to E19 were prepared by using the 
Continental method. Oil (POEs) and surfactant 
mixture were mixed thoroughly for 15 minutes at 750 
rpm in a beaker by using low shear mixer fixed with 
three blades (propeller). Piroxicam was added to the 
mixture and mixed for another 30 minutes until 
dissolved completely. Aqueous external phase 
(phosphate buffer of specified pH) containing sodium 
benzoate (0.01%) was added gradually to the above 
mixture and mixed for another 30 minutes. 
 
Droplet size measurement by photon correlation 
microscopy 
Droplet size of the dispersed phase globules of 
formulae E14 to E16 were measured by using 
Nanophox particle size analyzer, Sympatec Gmbh, 
Germany and Malvern zeta sizer 1000 HAS, Malvern 
Works, UK.  Both equipments measure and determine 
the globules size base on the basic principle of photon 
correlation microscopy. The samples were diluted 
with corresponding buffer of the external phase to get 
the K count in between 50-200. K count is a value 
that represents the number of particles contained in 
each sample.  
 
Droplet size measurement and structural study of 
the nano-cream formulations by transmission 
electron microscopy 
Transmission electron microscopy (TEM) was used to 
determine the size of droplets and to investigate the 
surface feature as well as the structure of the sample. 
TEM, Leo 912 AB Eftem was used for structural and 
droplets size measurements. Samples were placed on 
a formvar carbon-coated copper grid (200 mesh/inch) 
and then stained with 1% phosphotungstic acid. The 
excess phosphotungstic acid on the sample was gently 
wiped off using filter paper and these samples were 
examined after drying for about half an hour at room 
temperature. 
 
Zeta potential measurement of nano-cream 
formulations 
Zeta sizer, nano, Malvern UK was used to measure 
the zeta potential of the formulae. Formulations E14 
to E16 were diluted with the same buffer solution 
used as the external phase in formula to fix the ionic 
strength of each formula and to reduce the droplets 
count to suitable number which facilitates the 
monitoring of their movement. It is essential to make 
sure that bubbles were eliminated from the samples to 
prevent any change in the mobility of the droplets in 
the samples.  
 
Partition coefficient measurements of piroxicam 
between POEs and buffer 
Flask shaking method as explained by Qiao et al. was 
used in this study [12]. 50 ml of POEs was mixed 
separately with equal volume of pH 4, 6 and 7.4 
buffers in respective conical flask. 10 mg of 
piroxicam was added to each mixture in the flasks. 
The flasks were placed in thermostatic shaker bath, 
shaken at speed of 100 rpm and maintained at 
25±0.5ºC for 24 hr. The mixtures were transferred 
into separating funnel and left to separate. The 
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separated lower layer (buffer) was collected. The drug 
content in the lower layer was determined based on 
the absorption of UV light by using 
spectrophotometer at wavelength of 350 nm. The 
amount of drug present in the oil was calculated as 
the difference between the total amount added to the 
mixture (10 mg) and total drug dissolved in the buffer 
layer. The partition coefficient was calculated by the 
equations:   
Ko/w = (amount of drug in the oil / amount of drug in 
buffer) 
Log p = Log Ko/w 
 
Statistical analysis 
Graphpad software was used to calculate t-test. This 
test was used to determine the statistical significant 
difference between two formulations containing same 
characteristics and one variable. 
 
Results and discussion 
Based  on   pseudoternary  diagrams constructed (data  
not shown), the diagrams of HLB values of 12, 13.72 
and 15 containing different ratios of Tween 80 and 
Span 20 mixtures exhibited the best consistent and 
transparent areas. Where, Tween 80 and Span 20 
were mixed at different ratios to produce surfactants 
mixtures (emulsifier mixtures) having different HLB 
values. The ratios of the former and latter were 53:47 
for HLB 12, 80:20 for HLB 13.72 and 100:0 for HLB 
15. It is predicted that suitable micro or nano-
emulsions could be produced based on the 
compositions of mixtures within the area. Hence, 
different points in these diagrams were selected to 
assess their suitability to formulate nano-cream 
formulae for topical delivery. Table 1 shows the 
points selected as the ratio in percentage for the 
composition of water: oil: surfactant(s) as following: 
A 25:52:23 (%w/w), B 30:40:30 and C 37:25:38 
(%w/w) respectively. Characterization measurements 
were done on these points to determine the suitability 




Table 1. Details of compositions of emulsion formulae selected from the phase diagrams and mixture of 


















E1 52:25:23 S1 23:52 30.67 






25:37:38 S3 38:25 60.32 
E4 52:25:23 S4 23:52 30.67 
E5 40:30:30 S5 30:40 42.81 
E6 
13.72 80:20 
25:37:38 S6 38:25 60.32 
E7 52:25:23 S7 23:52 30.67 
E8 40:30:30 S8 30:40 42.81 
E9 
15 100:0 
25:37:38 S9 38:25 60.32 
 
Solubility measurements 
The solubility of piroxicam in POEs and in various 
combinations of oil and nonionic surfactant were 
determined to make sure that the desired piroxicam 
concentration of 0.5% could be achieved since the 
marketed   topical  preparations  of piroxicam  contain  
 
this strength of the drug. Table 2 shows that the 
solubility of piroxicam in POEs was very low, while 
its solubility in water was even lower. Increasing the 
pH of buffer resulted in higher solubility. When 
comparing the solubility in surfactant, the solubility 
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was found to be higher in Tween 80 as compared to 
its solubility in Span 20.  
 
Table 2. Solubility of piroxicam in various solvents 













On   the  other   hand,  table  3  shows  the  effect   of  
 
surfactant mixtures of different ratios and HLB values 
on the solubility of piroxicam in the solvents 
(mixtures of oil and surfactant). These points were 
selected from different previously studied 
pseudoternary phase diagrams. It is observed that as 
the HLB value of the system increases, the solubility 
of piroxicam increases, thereby, it could be seen that 
solvents containing surfactant mixture HLB 12 (lower 
Tween 80 and higher Span 20 concentration) had 
lower solubilization ability. By contrast, solvents 
containing surfactant at HLB 13.72 and HLB 15 
which contained 80 and 100% of Tween 80 
respectively were able to dissolve higher amount of 
piroxicam. This could be due to the solubilization 
effect of polyoxyethylene chains of Tween on 
NSAIDs [13]. The solubility of the drug in POEs also 
increased when the concentration of surfactant 
mixture in the solvent increase. 
 
Table 3. Solubility of piroxicam in various solvents containing surfactant mixtures of different ratios, 


















E1 S1 30.67(23:52) 1.38±0.18 
E2 S2 42.81(30:40) 3.32±0.21 
E3 
12 53:47 
S3 60.32(38:25) 5.65±0.21 
E4 S4 30.67(23:52) 1.54±0.47 
E5 S5 42.81(30:40) 5.57±0.22 
E6 
13.72 80:20 
S6 60.32(38:25) 8.19±0.29 
E7 S7 30.67(23:52) 1.78±0.28 
E8 S8 42.81(30:40) 7.23±0.30 
E9 
15 100:0 
S9 60.32(38:25) 10.59±0.38 
 
Rheological evaluation 
From the results of solubility studies, it was evident 
that only very little drug can be incorporated into 
solvents containing Tween 80 and Span 20 mixture of 
HLB 12 (S1, S2 and S3) and formulae E1, E2 and E3 
were withdrawn from further studies. Rheological 
study was conducted on E4 to E9 formulae which 
contain no piroxicam. Although the solubility of 
piroxicam in S4, S5 and S7 are also low, formulations 
E4, E5 and E7 which they are based from were 
included in the rheological study together with the 
selected E6, E8 and E9 formulae just to observe the 
roles of surfactants concentration on rheological 
behavior of the formulations produced. Based on the 
rheograms produced in rheological study carried out, 
all formulations (E4 to E9) were classified as 
viscoelastic or plastic type of flow because they 
possessed yield value. After the yield value was 
overcome, they showed pseudoplastic behaviour. 
 
Effect of surfactant HLB value on the rheological 
properties  
As can be seen from table 4, all formulations 
containing surfactant HLB 15 exhibited higher 
viscosity and yield value than those containing 
surfactant of lower HLB with E9 which contained 
Solvent Solubility (mg/g) 
Water 0.01±0.001 
POEs 1.09±0.04 
Phosphate buffer pH 4 0.03±0.004 
Phosphate buffer pH 6 0.07±0.012 
Phosphate buffer pH 7.4 0.52±0.08 
Tween 80 40.42±1.26 
Span 20 4.48±0.40 
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highest surfactant concentration showed maximum 
yield value and intrinsic viscosity of 165 Pa and 
91000 poise respectively. The use of single surfactant 
(Tween 80) at HLB15 may create a loosely packed 
film around the oil droplets as a result of the steric 
effect between the bulky head groups at the interface. 
The steric effect prevents the hydrocarbon chain from 
freely linking through the  van dar waal΄s forces [14]. 
Furthermore, Tween 80 is more soluble in the 
external aqueous phase. The combined effect of these 
two factors would be the migration of excess Tween 
80 to the external phase resulting in increasing the 
number of surfactant molecules to build micellar 
structure and aggregates which in turn raise the 
viscosity. The increased number of micelles and 
aggregations between the oil droplets will result in the 
formation of highly viscous system [15].  
 
Table 4. Effect of HLB of the surfactant mixture used on the rheological behaviour of the emulsion 
formulations E4 to E9. All data are presented as mean±SD, (n=3). 
 










E4 13.72 75 8475±360 
E7 15.00 52 25 23 90 36400±419 
E5 13.72 95 11506±40 
E8 15.00 40 30 30 130 76600±7388 
E6 13.72 115 14818±100 
E9 15.00 25 37 38 165 91100±911 
 
There was a statistically significant difference in the viscosity between formulations E4 and E7 (p < 0.0001), 
E5 and E8 (p<0.0001), E6 and E9 (p<0.0001). 
 
On the contrary, at HLB 13.72 the formulations 
contained the oil-loving Span 20 and water-loving 
Tween 80. In this situation, Tween 80 and Span 20 
may form a closely packed film at the interface, 
where the orientated hydrocarbon chain of Span 20 in 
the oil phase present in between the hydrocarbon 
chains of two neighboring Tween 80 molecules may 
form a firm link through van dar waal’s forces [16]. 
Hence, Tween 80 molecules will not be able to 
migrate freely to the external phase, where they are 
more soluble. As a result, there will be less 
aggregated Tween 80 structures and molecules in the 
external phase resulting in less formation of network. 
Therefore, lower yield value and viscosity were 
obtained.    
The rheological results obtained were in good 
correlation to that reported by Lashmar et al. [17] 
who stated that the plastic rheological properties were 
highly correlated to the network structures formed by 
the nonionic surfactant mixture in the external phase 
and around the droplets. 
 
 
Effect of surfactant concentration on the 
rheological behaviour of the tested formulae  
The effect of surfactant concentration at different 
HLB values on the rheological measurement was 
assessed by studying of the Rheological behaviour of 
formulations (E4, E5 and E6) of HLB 13.72 and (E7, 
E8 and E9) of HLB 15. It can be observed from Table 
5 that the increases in surfactant concentration lead to 
the increament of the intrinsic viscosity and yield 
value of the systems. This may be due to the presence 
of more Tween 80 in the formulations with higher 
surfactant concentrations. As the concentration of 
water soluble surfactant in the system increases, the 
self association of these amphiphilic molecules 
increases and forms different sizes and shapes of 
micellar aggregates [18]. As the concentration in 
external phase increases, the network will form 
between the surfactants molecules, micelles and oil 
droplets. The denser the network, the higher the yield 
value, the closer the distance between the dispersed 









Table 5. Effect of surfactant concentration on the  rheological behaviour of the emulsion formulations. All 















Effect of drug concentration on the intrinsic 
viscosity measurements of the tested formulae 
The drug was not soluble to the required extent in the 
solvents equivalent to those used in formulations of 
E4 and E5 at HLB 13.72. Therefore, only formulation 
E6 was selected to study the further effect of drug 
concentration and pH. At HLB 15, formula E9 
showed a very high yield value of 160 Pa and 
intrinsic viscosity of 91000 poise which makes it 
difficult to remove the sample from the container. In 
formulation E7, drug was not soluble to the required 
extent in the solvent used (Table 5). Therefore, at 
HLB 15, only formulation E8 was selected for further 
study. Formulae E6 at HLB13.72 containing 0.4 and 
0.5% piroxicam were designated as E10 and E11 and 
formula E8 at HLB15 containing 0.4 and 0.5% 
piroxicam were designated as E12 and E13. The 
details of the formulae are shown in table 6.  
Changing drug concentration (Table 6) demonstrated 
a non-significant effect of drug concentration on the 
intrinsic viscosity values of the prepared nano-cream. 
These results may indicate that the drug molecules 
did not form any crystalline structure within the 
concentration range studied that can affect system 
structure and did not alter the physicochemical 
properties of the oil and surfactant mixture used. 
There was no statistical significant difference among 
formulations E6, E10 and E11 (p= 0.3703), E8, E12 
and E13 (p= 0.8655). 
 
 
Effect of external phase pH value on the intrinsic 
viscosity measurement of the tested formulae 
Effect of pH was studied by replacing DW with three 
different pH phosphate buffers as the external phase. 
Formulations E11 and E13 containing 0.5% of 
piroxicam were chosen to be modified to study the 
effects of pH of aqueous phase since they contain the 
same percentage of piroxicam as the product available 
in market.  
 
Table 6: Effect of piroxicam concentration on the 
intrinsic viscosity of the selected formulations. All 
data are presented as mean±SD, (n=3). 
 
HLB 




E6 0% 14818±100 
E10 0.4% 14767±140 
13.72 
(80:20) 
E11 0.5% 14769±118 
E8 0% 76600±7388 
E12 0.4% 79700±6912 
15 
(100:0) 
E13 0.5% 78600±7008 
 
Note: E6, E10, E11 contain: (water:oil:surfactant) of (37:25:38) 
and E8, E12, E13 contain: (water:oil:surfactant) of (30:40:30). 
 
DW of the formulae was replaced by phosphate 
buffer of pH 4, pH 6 and pH 7.4 (0.2 M) to produce 
formulations E14 to E19 as in table 7.  
 
 











E4 52        25 23 75 8475±360 




13.72 E6 25 37 38 115 14818±100 
E7 52 25 23 90 36400±419 




E9 25 37 38 165 91100±911 
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From table 7 it can be observed that the change in pH 
did not give significant effect on the intrinsic 
viscosity of the systems.  These results agree with the 
fact that nonionic surfactants are known to not be 
affected by different pH and ionic conditions, thereby 
did not exert any change on the rheological behavior 
of the systems. Figure 1 shows the rheogram of one of 
the tested formulation where, the thixotropic 
hysteresis loop as well as the yield value is easily to 
be seen. The shear thinning like behavior after the 
yield value as well as the thixotropic hysteresis loop 
are the favorable characteristics and features of 
cosmetics, pharmaceutical creams and gel emulsions 
[19]. The curved rheograms after passing the initial 
yield value is correlated with the progressive 
disintegration of the network and deformation of the 
small droplets when continuously sheared at higher 
shear stress. This means, that the yield value is 
associated with the initial destruction or breakage of 
the network formed among oil droplets, surfactants 
molecules and surfactants micelles, followed by shear 
thinning behavior which correlated with the 
progressive or further breakage of the broken network 
and deformation of droplets [20]. This flow behavior 
is a desirable property in cosmetics and semisolid 
preparation since it is correlated with stability during 
storage where shear stress is less than yield value and 
easy flowability from the container and spreading 
onto the skin because of shear thinning properties at 
higher shear stress once the yield value is overcome 
[20]. 
 
Figure 1. Rheogram of formulation E4, HLB 
13.72. All data are presented as mean±SD, (n=3). 
Table 7. Effect of external phase pH value on the 
intrinsic viscosity of the selected formulae. All data 
are presented as mean±SD, (n=3). 
Droplet size measurement 
Formulae E14 to E16 were chosen for this study since 
their intrinsic viscosities were reasonably high but 
lower than the intrinsic viscosity of formulae E17 to 
E19 which were very high. Formulations having very 
high viscosity were not selected since the higher the 
viscosity, the slower is the drug diffusion and release 
from formula to be absorbed topically [21] result in a 
not very convenient formula to be applied to the skin. 
From table 8, it can be observed that the droplets sizes 
of all formulations were in the range of 130-140 nm. 
The concentration of the drug presented, did not alter 
the droplet size value significantly (p> 0.5).  There 
was no statistical significant difference between 
formulations E14 without and with 0.5% piroxicam 
(p= 0.8135), E15 with and without piroxicam (p= 
0.262) and E16 with and without piroxicam (p= 
0.3289).   
Similarly, the results of the studies also showed that 
pH did not affect the droplets size of the system. This 
could relate to the fact that non ionic surfactants are 
less affected by the pH and ionic strength of the 
media [4]. The mixture of nonionic surfactants of 
Tween 80: Span 20 at a ratio of 80:20 HLB 13.72 and 











E11        water 14818±100 
E14 (4) Buffer pH4 14858±95 






E16 (7.4) Buffer pH7.4 14858±89 
E13        water 76600±7388 
E17 (4) Buffer pH4 80200±6480 





E19 (7.4) Buffer pH7.4 77600±7194 
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reducing droplets size to around 130 nm. Non ionic 
surfactant mixtures were mentioned frequently as 
effective combination to achieve emulsion system 
with nano droplet size [22,23] .   
 
Table 8. Droplet size measurement of formulations 
E14, E15 and E16 with and without piroxicam at 






















Figure 2(a) is a TEM micrograph which shows that 
the droplet sizes of the sample were less than 100 nm. 
These results confirmed that the droplets of the 
emulsions are in nano size and the creams are nano-
cream. Although the size obtained by TEM is lower, 
the results obtained by photon correlation 
spectroscopy (Malvern, Nanophox) still valid because 
the size determined was in good approximation with 
TEM. The difference in the values obtained from the 
two methods is expected since they used different 
principles, one is based on the droplet projection and 
the other based on droplet diffraction. It is well 
documented that diameter or size determined by 
different methods are different and they may be 
normalized by conversion factor [24]. Figure 2(b) 
displays cylindrical structures of micellar aggregation 
and spherical oil droplets in the E16 nanocream 
system. These cylindrical structures are supposed to 
be responsible for the rigidity and high viscosity of 
the formulation [25]. 
 
Zeta Potential Measurements 
Zeta potential was measured to investigate the effects 
of drug and buffer solution of various pH on the 
electrostatic potential on the surface of oil droplets. 
Table 9 shows the zeta potential measurements with 
various external phase pH. It can be seen that droplets 
of prepared nano-cream possess a negatively charge 
zeta potential. These data are in accordance with the 
fact that the emulsions stabilized with non-ionic 
surfactants exhibits negative charge zeta potential.  
 
Table 9. Zeta potential and conductivity 
measurements of formulations E14, E15 and E16 
with and without piroxicam. All data are 













E14 -13±0.93 -1.1 0.06 
 
E15 -13.5±1.21 -1.13 0.06 0% 
 








13.86±0.31 -1.16 0.06 5% 
 
E16 -24.4±0.29 -1.92 0.09 
 
Additionally, systems with external phase pH 4 and 
pH 6 buffers showed zeta potential values lower than 
system with external phase pH 7.4. The negative 
charge on droplets surfaces stabilized by 
polyoxyethylene nonionic surfactant is originated 
from the adsorption of the (OH ¯) ion at the interface 
[26,27]. The (OH ¯) ion was supposed to dissociate 
from the external aqueous phase as a result of the 
aqueous (H+) ions binding to the polyoxyethylene 
chains. As a result, the dissociated (OH ¯) ions are 
able to adsorb at the interface shear plane zone. It can 
be concluded that the magnitude of the negative 
charge at the polyoxyethylene chain depends on the 
magnitude of the (OH ¯) group available in the 
external phase [28]. Phosphate buffer pH 7.4 contains 
higher NaOH amount, resulting in dissociation of 
more hydroxide ions compared to phosphate buffers 
pH 4 and 6. Hence, system containing phosphate 
buffer pH 7.4 as the external phase, may have 
exhibited a higher magnitude of negative zeta 
potential value through this mechanism.    
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Figure 2. (a) Droplet size measurement of 
formulation E16 by TEM, (b) structural image of 
formulation E16 obtained from TEM. 
  
On the other hand, the addition of the drug into the 
nano-cream system containing phosphate buffer pH 
7.4 as external phase demonstrated a significant 
increase in the value of zeta potential. While, there 
was no significant increase in zeta potential in nano-
cream systems containing buffers of pH 4 and 6 as 
external phase.  Piroxicam is a weak acid drug 
dissociates to a negatively charge compound and 
hydrogen ion. According to the Hasselbalch equation, 
the dissociation of weakly acidic compound is 
enhanced as the pH of the system increased. In 
addition, partition coefficient study also revealed that 
piroxicam partitioning was higher in phosphate buffer 
pH 7.4 compared to buffers pH 4 and 6. The negative 
charge of soluble piroxicam in buffer pH 7.4 is higher 
than that in pH 4 and 6 buffers. Therefore, the 
relatively higher concentration of piroxicam ion 
present in pH 7.4 external phase could contribute to 
higher negative zeta potential at this pH. There was 
no significant difference for formulations E14 and 
E15 with and without 0.5% piroxiam (p= 0.123) and 
(p= 0.271) respectively. The difference for E16 with 
and without piroxicam was found to be significant 
(p= 0.002).   
 
Partition coefficient measurements of piroxicam 
Piroxicam partition coefficient into buffers of 
different pH was assessed. The values are useful to 
relate with the release, transfer and penetration of the 
drug into the skin which could affect the 
pharmacodynamic activity of the drug. Accordingly, 
it was not surprising that the weakly acidic property 
of piroxicam makes it more soluble at higher pH 
value. As presented in table 10, the solubility of 
piroxicam was approximately 7, 15 and 50 times 
higher in phosphate buffer pH 7.4 than in phosphate 
buffers pH 6, pH 4 and water respectively.  
 
Table 10.  Solubility and partition coeffecient of 
piroxicam between POEs and different pH 
















buffer pH 4 34±3.8 





buffer pH 6 74±11.5 





buffer pH 7.4 519±84.0 
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As the pH value of buffer solution increases, the 
higher to ionization and solubility of the drug, this 
lead to higher amount of the drug partitioned into the 
aqueous phase and lowered the partition coefficient. 
 
Conclusions 
It can be concluded from this study that POEs is a 
promising and suitable oil that can be used to prepare 
nano-cream for topical delivery. On the other hand, 
piroxicam solubility is enhanced as the basicity or pH 
of the solvent increased. Additionally, elevating HLB 
value of surfactant was also found to enhance 
piroxicam solubility. Rheologically, it can be seen 
that increasing of surfactant hydrophilicity and 
concentration resulted in higher yield value and 
intrinsic viscosity of the formulations. Accordingly, 
Droplets sizes were around 130 nm (determined by 
zeta sizer) and lower than 100 nm (when determined 
by TEM), hence, it is evident that a nano-cream was 
produced. Zeta potential measurements were -20 
millivolts which could hinder the coalescence and 
aggregation of the oil droplets that indicate a stable 
nano-cream production. Lastly, the formulation 
consisted of 0.5% piroxicam with phosphate buffer 
(0.2M)  of pH 7.4 as the aqueous phases, POE as the 
oil phase and mixture of Tween 80: Span 20 (80:20) 
HLB 13.72 at the  ratio of 37: 25: 38 was chosen as 
the best formulation since it exhibited suitable nano-
cream topical characteristics. 
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